Evidence map›Paper›PMID 17646383›Full record

ArticleMolecular and cellular biology2007

Downregulation of Rap1GAP contributes to Ras transformation.

Oxana M Tsygankova, Gregory V Prendergast, Kanchan Puttaswamy, Yan Wang, Michael D Feldman, Hongbin Wang, Marcia S Brose, Judy L Meinkoth

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Downregulation of Rap1GAP Expression Activates the TGF-BioMed research international · 2021
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Inhibitory effects of Rap1GAP overexpression on proliferation and migration of endothelial cells via ERK and Akt pathways.Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Oxana M TsygankovaDepartment of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6061, USA.
Gregory V Prendergast
Kanchan Puttaswamy
Yan Wang
Michael D Feldman
Hongbin Wang
Marcia S Brose
Judy L Meinkoth
University of Pennsylvania · US

Funding

SIGNALING CROSSTALK AND THYROID CELL SURVIVALR01DK055757 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI MEINKOTH, JUDY L · 2000 to 2007
$2.1M
NIDDK NIH HHS DK55757NIDDK NIH HHS R01 DK055757
6 · The paper itself

Abstract

Although abundant in well-differentiated rat thyroid cells, Rap1GAP expression was extinguished in a subset of human thyroid tumor-derived cell lines. Intriguingly, Rap1GAP was downregulated selectively in tumor cell lines that had acquired a mesenchymal morphology. Restoring Rap1GAP expression to these cells inhibited cell migration and invasion, effects that were correlated with the inhibition of Rap1 and Rac1 activity. The reexpression of Rap1GAP also inhibited DNA synthesis and anchorage-independent proliferation. Conversely, eliminating Rap1GAP expression in rat thyroid cells induced a transient increase in cell number. Strikingly, Rap1GAP expression was abolished by Ras transformation. The downregulation of Rap1GAP by Ras required the activation of the Raf/MEK/extracellular signal-regulated kinase cascade and was correlated with the induction of mesenchymal morphology and migratory behavior. Remarkably, the acute expression of oncogenic Ras was sufficient to downregulate Rap1GAP expression in rat thyroid cells, identifying Rap1GAP as a novel target of oncogenic Ras. Collectively, these data implicate Rap1GAP as a putative tumor/invasion suppressor in the thyroid. In support of that notion, Rap1GAP was highly expressed in normal human thyroid cells and downregulated in primary thyroid tumors.

Indexed as

Cell Transformation, NeoplasticDown-RegulationAnimalsCell Line, TumorCell MovementCell ProliferationExtracellular Signal-Regulated MAP KinasesGTPase-Activating ProteinsHumansras ProteinsRatsThyroid GlandThyroid NeoplasmsExtracellular Signal-Regulated MAP KinasesGTPase-Activating ProteinsRAP1GAP protein, humanras Proteins

Identifiers

PMID17646383
PMCPMC2099240
OpenAlexW2124400367

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.